GPX4 and neoplasm: GPX4 deficiency in Treg cells increases the production of mitochondrion-derived superoxide and interleukin-1β that promotes T helper 17 responses, thereby repressing tumor growth and concomitantly potentiating antitumor immunity (Xu et al., 2021).